158 related articles for article (PubMed ID: 25837468)
21. Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo.
Han HS; Lee J; Kim HR; Chae SY; Kim M; Saravanakumar G; Yoon HY; You DG; Ko H; Kim K; Kwon IC; Park JC; Park JH
J Control Release; 2013 Jun; 168(2):105-14. PubMed ID: 23474029
[TBL] [Abstract][Full Text] [Related]
22. Tumor-targeting and pH-responsive nanoparticles from hyaluronic acid for the enhanced delivery of doxorubicin.
Liao J; Zheng H; Fei Z; Lu B; Zheng H; Li D; Xiong X; Yi Y
Int J Biol Macromol; 2018 Jul; 113():737-747. PubMed ID: 29505869
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of hyaluronic acid-based polymersomes for doxorubicin delivery to metastatic breast cancer.
Shahriari M; Taghdisi SM; Abnous K; Ramezani M; Alibolandi M
Int J Pharm; 2019 Dec; 572():118835. PubMed ID: 31726198
[TBL] [Abstract][Full Text] [Related]
24. Heparin-deoxycholic acid chemical conjugate as an anticancer drug carrier and its antitumor activity.
Park K; Lee GY; Kim YS; Yu M; Park RW; Kim IS; Kim SY; Byun Y
J Control Release; 2006 Sep; 114(3):300-6. PubMed ID: 16884806
[TBL] [Abstract][Full Text] [Related]
25. Facile preparation of core cross-linked nanomicelles based on graft copolymers with pH responsivity and reduction sensitivity for doxorubicin delivery.
Chen T; Xiao Y; Lu W; Liu S; Gan L; Yu J; Huang J
Colloids Surf B Biointerfaces; 2018 Jan; 161():606-613. PubMed ID: 29156337
[TBL] [Abstract][Full Text] [Related]
26. Doxorubicin‑loaded dual‑functional hyaluronic acid nanoparticles: Preparation, characterization and antitumor efficacy in vitro and in vivo.
Tian G; Sun X; Bai J; Dong J; Zhang B; Gao Z; Wu J
Mol Med Rep; 2019 Jan; 19(1):133-142. PubMed ID: 30483793
[TBL] [Abstract][Full Text] [Related]
27. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells.
Zhao Q; Liu J; Zhu W; Sun C; Di D; Zhang Y; Wang P; Wang Z; Wang S
Acta Biomater; 2015 Sep; 23():147-156. PubMed ID: 25985912
[TBL] [Abstract][Full Text] [Related]
28. Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery.
Yang Y; Zhao Y; Lan J; Kang Y; Zhang T; Ding Y; Zhang X; Lu L
Int J Nanomedicine; 2018; 13():4361-4378. PubMed ID: 30100720
[TBL] [Abstract][Full Text] [Related]
29. Biological evaluation of redox-sensitive micelles based on hyaluronic acid-deoxycholic acid conjugates for tumor-specific delivery of paclitaxel.
Li J; Yin T; Wang L; Yin L; Zhou J; Huo M
Int J Pharm; 2015 Apr; 483(1-2):38-48. PubMed ID: 25655715
[TBL] [Abstract][Full Text] [Related]
30. Nanoparticles of deoxycholic acid, polyethylene glycol and folic acid-modified chitosan for targeted delivery of doxorubicin.
Shi Z; Guo R; Li W; Zhang Y; Xue W; Tang Y; Zhang Y
J Mater Sci Mater Med; 2014 Mar; 25(3):723-31. PubMed ID: 24327111
[TBL] [Abstract][Full Text] [Related]
31. Preparation, characterization and systemic application of self-assembled hydroxyethyl starch nanoparticles-loaded flavonoid Morin for hyperuricemia therapy.
Li J; Yang Y; Lu L; Ma Q; Zhang J
Int J Nanomedicine; 2018; 13():2129-2141. PubMed ID: 29692610
[TBL] [Abstract][Full Text] [Related]
32. The use of amino acid linkers in the conjugation of paclitaxel with hyaluronic acid as drug delivery system: synthesis, self-assembled property, drug release, and in vitro efficiency.
Xin D; Wang Y; Xiang J
Pharm Res; 2010 Feb; 27(2):380-9. PubMed ID: 19876721
[TBL] [Abstract][Full Text] [Related]
33. Cationic nanoparticles self-assembled from amphiphilic chitosan derivatives containing poly(amidoamine) dendrons and deoxycholic acid as a vector for co-delivery of doxorubicin and gene.
Chen S; Deng J; Zhang LM
Carbohydr Polym; 2021 Apr; 258():117706. PubMed ID: 33593576
[TBL] [Abstract][Full Text] [Related]
34. Hyaluronic acid and cholecalciferol conjugate based nanomicelles: Synthesis, characterization, and cytotoxicity against MCF-7 breast cancer cells.
Gao N; Fu Y; Gong H; Liu H; Li W
Carbohydr Res; 2022 Dec; 522():108706. PubMed ID: 36274357
[TBL] [Abstract][Full Text] [Related]
35. Layer-by-layer pH-sensitive nanoparticles for drug delivery and controlled release with improved therapeutic efficacy
Men W; Zhu P; Dong S; Liu W; Zhou K; Bai Y; Liu X; Gong S; Zhang S
Drug Deliv; 2020 Dec; 27(1):180-190. PubMed ID: 31924103
[TBL] [Abstract][Full Text] [Related]
36. Novel hyaluronic acid (HA) coated drug carriers (HCDCs) for human breast cancer treatment.
Hyung W; Ko H; Park J; Lim E; Park SB; Park YJ; Yoon HG; Suh JS; Haam S; Huh YM
Biotechnol Bioeng; 2008 Feb; 99(2):442-54. PubMed ID: 17625788
[TBL] [Abstract][Full Text] [Related]
37. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
[TBL] [Abstract][Full Text] [Related]
38. Deoxycholic acid modified-carboxymethyl curdlan conjugate as a novel carrier of epirubicin: in vitro and in vivo studies.
Gao F; Li L; Zhang H; Yang W; Chen H; Zhou J; Zhou Z; Wang Y; Cai Y; Li X; Liu L; Zhang Q
Int J Pharm; 2010 Jun; 392(1-2):254-60. PubMed ID: 20347028
[TBL] [Abstract][Full Text] [Related]
39. Tumor microenvironment dual-responsive core-shell nanoparticles with hyaluronic acid-shield for efficient co-delivery of doxorubicin and plasmid DNA.
Wang T; Yu X; Han L; Liu T; Liu Y; Zhang N
Int J Nanomedicine; 2017; 12():4773-4788. PubMed ID: 28740384
[TBL] [Abstract][Full Text] [Related]
40. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base.
Li F; Zheng C; Xin J; Chen F; Ling H; Sun L; Webster TJ; Ming X; Liu J
Int J Nanomedicine; 2016; 11():3875-90. PubMed ID: 27574421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]